Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Team Novo Nordisk Announces 2017 Roster
  • USA - English


News provided by

PRO Sports Communications

Nov 17, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Team Novo Nordisk announces 2017 roster.
Team Novo Nordisk announces 2017 roster.

Atlanta, Georgia (PRWEB) November 17, 2016 -- Team Novo Nordisk, the world’s first all-diabetes professional cycling team, will race its fifth season with an expanded roster of 19 athletes from eight countries. Six new riders, including stagiaires Quentin Valognes (FRA) and Rik van IJzendoorn (NED), both who raced with the men’s professional team since August, are part of Team Novo Nordisk’s 2017 roster.

In 2016, we earned more top five results than any season, and we are eager to keep building on these results to inspire, educate and empower everyone around the world affected by diabetes.

Post this

"Team Novo Nordisk is ready to take on its fifth season with our largest squad to date. We're all excited to see what these talented athletes, especially the five riders coming up from our development squad, can accomplish in 2017," Team Novo Nordisk CEO and co-founder Phil Southerland said. “In 2016, we earned more top five results than any season, and we are eager to keep building on these results to inspire, educate and empower everyone around the world affected by diabetes.”

In order to become a member of Team Novo Nordisk, all athletes must have type 1 diabetes. Since its launch in December 2012, the organization has focused heavily on identifying and developing endurance athletes from around the world with diabetes, building junior and development squads currently totaling 31 athletes.

Five of Team Novo Nordisk’s six new athletes are products of its development program. Fabio Calabria (AUS), Reid McClure (CAN), Umberto Poli (ITA), Valognes and van IJzendoorn all spent at least one season racing on the development squad; Valognes has been with Team Novo Nordisk since its inception in 2013. Standout results from these riders include (all 2016 unless otherwise noted):

• Calabria:
o 1st, Alabama State Road Race Championship
o 3rd, Mt. Victory Road Race

• McClure:
o 1st, Tennessee State Road Race Championship
o 2nd, Georgia Cycling Gran Prix, Stage 4
o 2nd, Foothills Cup Road Race

• Poli:
o 1st, Georgia Cycling Grand Prix, Stage 2
o 1st, Georgia Cycling Grand Prix, Stage 6
o 2nd, Mt. Victory Road Race
o 2nd, Belgian Kermesse

• Valognes:
o 9th, Tour of Yancheng Coastal Wetlands **as stagiaire with men’s professional team
o 1st, Tour de l’Abitibi Desjardins, Stage 5 (2014)
o 1st, Tour de l’Abitibi Desjardins, Stage 6 (2014)
o 3rd, French National Keirin Championship (2014)

• Van IJzendoorn:
o 4th, Healthy Newton Omnium
o 5th, Mt. Victory Road Race

Newcomer Romain Gioux (FRA) approached the team after racing as an amateur for French team’s Cycliste de Varennes-Vauzelles and Vélo Sport Chartrain. In late 2016, Gioux was asked to race with the team’s development squad at the East Bohémia Tour. His performance there earned him a contract for the 2017 season.

"We have spent four years nurturing our development program and it is rewarding to move five devo riders up to our pro squad. Each of these riders adds depth to our team, and we are excited to witness their years with our development team turn into results within the pro ranks,” Team Novo Nordisk Senior Vice President of Athletics Vassili Davidenko said. "We strengthened our men’s pro team with these new riders and added new staff. We believe these changes will lead to more results.”

This season, the Team Novo Nordisk men’s professional squad competed in its first World Tour stage race, Tour de Pologne. Across 43 races in 23 countries, Team Novo Nordisk earned its best overall result to date when Javier Megias (ESP) finished second overall at the Tour of Korea. The Spaniard went on to earn the team its best finish at a UCI 2.HC race when he took 14th overall at the Tour of California. Other highlights of the season include Martijn Verschoor (NED) sprinting to fifth on Stage 1 of the Tour of California and the team winning its first team classification at the Tour of Estonia. As of November 16, 2016, the team has amassed a total of nine top five finishes, the most in its four-year history.

The full 2017 roster includes:

Andrea Peron – ITA
Brian Kamstra – NED
Charles Planet – FRA
Chris Williams – AUS
Corentin Cherhal - FRA
David Lozano – ESP
Fabio Calabria - AUS
Gerd de Keijzer - NED
James Glasspool - AUS
Javier Megias – ESP
Joonas Henttala – FIN
Martijn Verschoor – NED
Mehdi Benhamouda - FRA
Quentin Valognes – FRA
Reid McClure - CAN
Rik van IJzendoorn – NED
Romain Gioux - FRA
Stephen Clancy – IRL
Umberto Poli - ITA

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists, triathletes and runners, spearheaded by the world’s first all-diabetes UCI Professional Continental cycling team. The team’s mission is to inspire, educate and empower those affected by diabetes.

Katrina Younce, PRO Sports Communications, http://www.prosportscomm.com, +1 (310) 995-3619, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.